Skip to main content
Log in

Radiopharmaceuticals in sentinel lymph-node detection – an overview

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract.

Biopsy of the first tumour-draining lymph node (sentinel node, SN) is bound to become the procedure of choice in regional staging of melanoma and breast cancer patients. Several radiopharmaceuticals have been developed for lymphoscintigraphy. In this paper we review the most frequently used radiopharmaceuticals for their appropriateness in the sentinel-node procedure. We conclude that accurate localization of SNs is demonstrated using technetium-99m-sulfur colloid (99mTc-SC), 99mTc antimony trisulfide colloid (99mTc-ATC) [10] and 99mTc nanocolloidal albumin (99mTc-CA). 99mTc-Ca and 99mTc-SC are both available in Europe. In the United States 99mTc-SC is the only registered tracer for lymphoscintigraphy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilhelm, A., Mijnhout, G. & Franssen, E. Radiopharmaceuticals in sentinel lymph-node detection – an overview. Eur J Nucl Med 26 (Suppl 1), S36–S42 (1999). https://doi.org/10.1007/PL00014793

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00014793

Navigation